|
|
Volumn 19, Issue , 2002, Pages S27-S32
|
|
Alemtuzumab in T-cell malignancies
a
|
|
Author keywords
Alemtuzumab; Campath 1H; Leukemia; Lymphoma; Prolymphocytic; T cell
|
|
Indexed keywords
ALEMTUZUMAB;
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
CD52 ANTIGEN;
GLYCOPROTEIN;
LEUKOCYTE ANTIGEN;
MONOCLONAL ANTIBODY;
TUMOR ANTIGEN;
ACICLOVIR;
ANTIBIOTIC AGENT;
ANTIHISTAMINIC AGENT;
ANTIVIRUS AGENT;
CAMPATH 1G;
CHLORAMBUCIL;
COTRIMOXAZOLE;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN A;
DOXORUBICIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
METHOTREXATE;
PARACETAMOL;
PENTOSTATIN;
PREDNISONE;
VINCRISTINE;
AGED;
CLINICAL TRIAL;
DRUG EFFECT;
FEMALE;
GENETICS;
HUMAN;
MALE;
MIDDLE AGED;
MORTALITY;
REVIEW;
T CELL LYMPHOMA;
ANTIGEN EXPRESSION;
ARTICLE;
CANCER IMMUNOTHERAPY;
CHRONIC LYMPHATIC LEUKEMIA;
DRUG ACTIVITY;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG RESPONSE;
DRUG TARGETING;
DRUG TOLERABILITY;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN T CELL LEUKEMIA VIRUS 1;
INFECTION;
LARGE GRANULAR LYMPHOCYTE;
LYMPHOCYTOPENIA;
MINIMAL RESIDUAL DISEASE;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
PROGNOSIS;
PROMYELOCYTIC LEUKEMIA;
T CELL LEUKEMIA;
T LYMPHOCYTE;
VIRUS INFECTION;
VIRUS REACTIVATION;
AGED;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
ANTIGENS, CD;
ANTIGENS, NEOPLASM;
ANTINEOPLASTIC AGENTS;
CLINICAL TRIALS;
FEMALE;
GLYCOPROTEINS;
HUMANS;
LYMPHOMA, T-CELL;
MALE;
MIDDLE AGED;
HUMAN;
MIDDLE AGE;
|
|
EID: 0036275123
PISSN: 13570560
EISSN: None
Source Type: Journal
DOI: 10.1385/MO:19:2S:S27 Document Type: Article |
|
Times cited : (59)
|
|
References (18)
|
